DB:NTU

Stock Analysis Report

Neptune Wellness Solutions

Executive Summary

Neptune Wellness Solutions Inc., a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.

Risks

  • Neptune Wellness Solutions has significant price volatility in the past 3 months.
  • Neptune Wellness Solutions is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has Neptune Wellness Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-5.2%

DB:NTU

1.2%

DE Personal Products

0.8%

DE Market


1 Year Return

27.5%

DB:NTU

10.3%

DE Personal Products

-10.9%

DE Market

NTU outperformed the Personal Products industry which returned 11% over the past year.

NTU outperformed the Market in Germany which returned -9.7% over the past year.


Share holder returns

NTUIndustryMarket
7 Day-5.2%1.2%0.8%
30 Day-30.6%-1.6%-5.9%
90 Day4.5%-1.2%-2.9%
1 Year27.5%27.5%12.9%10.3%-8.1%-10.9%
3 Yearn/a42.7%33.1%10.4%0.9%
5 Yearn/a97.6%76.2%25.4%8.0%

Price Volatility Vs. Market

How volatile is Neptune Wellness Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Neptune Wellness Solutions undervalued based on future cash flows and its price relative to the stock market?

6.5x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Neptune Wellness Solutions to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Neptune Wellness Solutions to establish if it is available at substantial discount.


Price Based on Earnings

Neptune Wellness Solutions is loss making, we can't compare its value to the Europe Personal Products industry average.

Neptune Wellness Solutions is loss making, we can't compare the value of its earnings to the Germany market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Neptune Wellness Solutions, we can't assess if its growth is good value.


Price Based on Value of Assets

Neptune Wellness Solutions is overvalued based on assets compared to the Europe Personal Products industry average.


Next Steps

Future Growth

How is Neptune Wellness Solutions expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

160.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Neptune Wellness Solutions's revenue is expected to grow significantly at over 20% yearly.

Neptune Wellness Solutions's earnings are expected to grow significantly at over 20% yearly.

Neptune Wellness Solutions's revenue growth is expected to exceed the Germany market average.

Neptune Wellness Solutions's earnings growth is expected to exceed the Germany market average.

Neptune Wellness Solutions's earnings growth is expected to exceed the low risk savings rate of 0.2%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Neptune Wellness Solutions will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Neptune Wellness Solutions performed over the past 5 years?

18.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Neptune Wellness Solutions does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Neptune Wellness Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Neptune Wellness Solutions's 1-year growth to the Europe Personal Products industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Neptune Wellness Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Neptune Wellness Solutions has efficiently used its assets last year compared to the Europe Personal Products industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Neptune Wellness Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Neptune Wellness Solutions's financial position?


Financial Position Analysis

Neptune Wellness Solutions is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Neptune Wellness Solutions's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Neptune Wellness Solutions's level of debt (6.6%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (12.6% vs 6.6% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 4.3x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Neptune Wellness Solutions has less than a year of cash runway based on current free cash flow.

Neptune Wellness Solutions has less than a year of cash runway if free cash flow continues to grow at historical rates of 60.2% each year.


Next Steps

Dividend

What is Neptune Wellness Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Neptune Wellness Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Neptune Wellness Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Neptune Wellness Solutions has not reported any payouts.

Unable to verify if Neptune Wellness Solutions's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Neptune Wellness Solutions has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Neptune Wellness Solutions's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Michael Cammarata 0

0.1yrs

Tenure

0

Mr. Michael Cammarata serves as Chief Executive Officer and Director at Neptune Wellness Solutions Inc. since July 08, 2019. He is the Founder at Random Occurrence. He has been a serial entrepreneur, devel ...


Management Age and Tenure

1.9yrs

Average Tenure

The average tenure for the Neptune Wellness Solutions management team is less than 2 years, this suggests a new team.


Board Age and Tenure

11.8yrs

Average Tenure

The average tenure for the Neptune Wellness Solutions board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

More shares have been bought than sold by Neptune Wellness Solutions individual insiders in the past 3 months.


Recent Insider Transactions

BuyCA$1,781,80222 Jul 19
Michael Cammarata
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares454,546
Max PriceCA$3.92
BuyCA$783,99222 Jul 19
Schottenfeld Group Holdings Lp
EntityCompany
Shares200,000
Max PriceCA$3.92
BuyCA$97,99922 Jul 19
Martin Landry
EntityIndividual
Shares25,000
Max PriceCA$3.92
BuyCA$2,672,69922 Jul 19
John Moretz
EntityIndividual
Role
Chairman of the Board
Chairman
Shares681,818
Max PriceCA$3.92
BuyCA$25,57717 May 19
John Moretz
EntityIndividual
Role
Chairman of the Board
Chairman
Shares7,600
Max PriceCA$3.37
BuyCA$165,43626 Feb 19
John Moretz
EntityIndividual
Role
Chairman of the Board
Chairman
Shares68,491
Max PriceCA$2.44
BuyCA$20,35322 Feb 19
John Moretz
EntityIndividual
Role
Chairman of the Board
Chairman
Shares6,335
Max PriceCA$3.21
BuyCA$399,70920 Feb 19
John Moretz
EntityIndividual
Role
Chairman of the Board
Chairman
Shares124,554
Max PriceCA$3.21
SellCA$213,71126 Sep 18
Schottenfeld Group Holdings Lp
EntityCompany
Shares54,000
Max PriceCA$3.96
SellCA$938,41026 Sep 18
Richard Schottenfeld
EntityIndividual
Shares237,115
Max PriceCA$3.96
BuyCA$64,99926 Sep 18
Schottenfeld Group Holdings Lp
EntityCompany
Shares20,000
Max PriceCA$3.25
SellCA$27,70007 Sep 18
Jacqueline Khayat
EntityIndividual
Shares7,500
Max PriceCA$3.69
SellCA$8,72705 Sep 18
Jacqueline Khayat
EntityIndividual
Shares2,500
Max PriceCA$3.49
SellCA$139,97031 Aug 18
Marc Vaugeois
EntityIndividual
Role
Head of Sales
Vice President of Sales
Shares40,000
Max PriceCA$3.50
SellCA$17,32431 Aug 18
Jacqueline Khayat
EntityIndividual
Shares5,000
Max PriceCA$3.46

Ownership Breakdown


Management Team

  • Mario Paradis

    VP & CFO

    • Tenure: 4.0yrs
    • Compensation: CA$509.23k
  • Michel Timperio

    President of Cannabis Business

    • Tenure: 1.9yrs
    • Compensation: CA$413.44k
  • Roger Corriveau (71yo)

    Vice-President of Business Development

    • Tenure: 0.0yrs
    • Compensation: CA$91.20k
  • Marc Vaugeois

    Vice President of Sales

    • Tenure: 1.6yrs
    • Compensation: CA$816.77k
  • Jean-Daniel Bélanger

    VP of Legal Affairs & Corporate Secretary

    • Tenure: 2.2yrs
    • Compensation: CA$253.77k
  • John Ripplinger

    Director of Investor Relations

    • Tenure: 0.0yrs
  • Jim Hamilton

    • Tenure: 0.1yrs
    • Compensation: CA$619.44k
  • Etienne Villeneuve

    Head of Operations & Technical Services

    • Tenure: 2.8yrs
  • Sabrina Di Blasio

    Director of Marketing & Communications

    • Tenure: 0.0yrs
  • Michael Cammarata

    CEO & Director

    • Tenure: 0.1yrs

Board Members

  • Katherine Crewe

    Independent Director

    • Tenure: 4.1yrs
    • Compensation: CA$52.50k
  • John Moretz (69yo)

    Chairman

    • Tenure: 2.0yrs
    • Compensation: CA$266.53k
  • Steven Nissen

    Member of the Scientific Advisory Board

    • Tenure: 11.8yrs
  • Ronald Denis (65yo)

    Independent Director

    • Tenure: 19.6yrs
    • Compensation: CA$48.00k
  • Melvin Dionne

    Member of the Scientific Advisory Board

    • Tenure: 11.8yrs
  • Demian Barbas

    Member of the Scientific Advisory Board

    • Tenure: 11.8yrs
  • Magdy Abdel-Malik

    Member of the Scientific Advisory Board

    • Tenure: 11.8yrs
  • Thomas Hartman

    Member of the Scientific Advisory Board

    • Tenure: 11.8yrs
  • Hélène Fortin

    Director

    • Tenure: 1.0yrs
    • Compensation: CA$125.95k
  • Michael Cammarata

    CEO & Director

    • Tenure: 0.1yrs

Company Information

Neptune Wellness Solutions Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Neptune Wellness Solutions Inc.
  • Ticker: NTU
  • Exchange: DB
  • Founded: 1998
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: CA$528.011m
  • Listing Market Cap: CA$356.332m
  • Shares outstanding: 92.47m
  • Website: https://neptunecorp.com

Number of Employees


Location

  • Neptune Wellness Solutions Inc.
  • 100-545 Promenade du Centropolis
  • Laval
  • Quebec
  • H7T 0A3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NEPTTSX (The Toronto Stock Exchange)YesCommon SharesCACADJul 2001
NEPTNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDJul 2001
NTUDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2001

Biography

Neptune Wellness Solutions Inc., a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products. The company operates  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/23 22:11
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.